Heart valve replacements are critical for patients with valve malfunctions, and the tri-leaflet mechanical heart valve (tMHV) is one of the most durable options available. The tMHV is used to replace malfunctioning heart valves, restoring normal blood flow with exceptional durability, often lasting up to 20 years without needing replacement. This durability makes tMHVs particularly suitable for patients under 60. However, mechanical issues like cavitation can undermine the valve's functionality, posing risks to both its longevity and the overall efficacy of cardiovascular treatments. While previous studies have investigated some aspects of cavitation in these valves, the combined effects of blood viscosity and fluid-structure interaction (FSI) on cavitation dynamics remain insufficiently explored.This work models and numerically simulate the influence of blood viscosity on cavitation within tMHVs, using FSI principles. A detailed geometric model of the tMHV was developed, incorporating experimental data and non-Newtonian fluid behaviour to accurately replicate blood flow. Simulations were conducted in ANSYS Fluent R1® using a transient solver to capture the dynamic FSI, with the Carreau-Yasuda model representing blood's shear-dependent viscosity. Cavitation was observed at pressures as low as 4.5 Pa—well below the 15-20 Pa range typically reported—indicating a higher vulnerability than previously recognized. The simulations further showed significant vapour bubble formation, with the maximum vapour volume fraction reaching 0.953. High-speed leakage flows, peaking at 11 m/s during valve closure, were also noted, considerably exceeding velocities observed in earlier studies.These findings demonstrate that cavitation occurs when blood pressure drops below vapour pressure, causing vapour bubbles to form. These bubbles generate shock waves that can damage the valve surfaces and surrounding tissue. Insights from this study will aid in the design of next-generation tMHVs with optimised flow dynamics, potentially reducing cavitation risks and enhancing patient outcomes by minimising valve-associated complications.
Read full abstract